Glucose monitoring and the economy
MD&DI 21 August 2012 0:00
GlySure CEO Christopher Jones took part in a Q&A
with Medical Device & Diagnostic Industry
contributing writer John Conroy during which Jones discussed the
company's ICU pilot trial results, U.S. and European regulatory
approval paths, go to market strategy, and venture capital
funding.